Skip to content
Funds

Three vehicles, three theses.

InsurTech, ImpactTech and IndustryTech. Narrow by design: we invest where our partners have operated, and we say so early when a company sits outside that.

Thesis

  • InsurTech

    Insurance distribution, underwriting and claims are being rebuilt by companies that sell into insurers rather than around them. We back the ones a carrier can actually deploy, and we invest alongside the carriers we operate for, so a portfolio company arrives with a named counterpart rather than a cold introduction.

  • ImpactTech

    Impact that is measured, not asserted. We back companies whose social or environmental outcome is produced by the business model itself rather than reported alongside it, which is also the only kind that survives a downturn: it does not depend on a budget line anyone can cut.

  • IndustryTech

    AI, IoT and robotics applied to industry, where the hard part is making something physical at a cost that works. These companies are routinely told by generalist investors that their gross margin is wrong. Our IndustryTech partner built and sold a hardware company; the diligence question we ask is about the bill of materials at volume, not about the pitch.

Focus areas

InsurTech

  • Distribution and embedded insurance
  • Underwriting and pricing
  • Claims automation
  • Health and protection

ImpactTech

  • Inclusive employment and skills
  • Impact measurement infrastructure
  • Health and physical wellbeing
  • Resource efficiency

IndustryTech

  • Industrial AI and computer vision
  • Robotics and automation
  • Connected devices and IoT
  • Critical materials and sovereignty

Portfolio

Companies whose status is sourced. The full list is published when display rights are confirmed.

Think you fit this thesis?

One line on what you do and why now. We read everything and we answer either way.

Clicking loads a third-party service (Shopinzen), which sets analytics cookies. Nothing loads before that.